{"id":"W1978182027","doi":"10.1038/npp.2014.214","title":"Evidence that Formulations of the Selective MAO-B Inhibitor, Selegiline, which Bypass First-Pass Metabolism, also Inhibit MAO-A in the Human Brain","year":2014,"lang":"en","type":"article","venue":"Neuropsychopharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Brookhaven National Laboratory; Biological and Environmental Research; National Institute on Drug Abuse; National Institutes of Health; Valeant Pharmaceuticals International; American Academy of Neurology; U.S. Department of Energy","keywords":"Selegiline; Monoamine oxidase B; Pharmacology; Clorgyline; Antidepressant; CYP2D6; Amphetamine; Monoamine oxidase; Dopamine; Chemistry; Internal medicine; Endocrinology; Medicine; Metabolism; Parkinson's disease; Enzyme; Biochemistry; Cytochrome P450; Hippocampus","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002897363,0.0003034995,0.0001896632,0.0002136902,0.0001525215,0.0002862438,0.0001847384,0.0004496542,0.003803052],"category_scores_gemma":[0.0005432783,0.000186721,0.0003217082,0.0001742902,0.0003533331,0.0001798156,0.0001690698,0.0005109094,0.0004500561],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002336314,"about_ca_system_score_gemma":0.0002013986,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001856222,"about_ca_topic_score_gemma":0.002153121,"domain_scores_codex":[0.9998636,0.00004188764,0.000009733871,0.00003498628,0.00003967226,0.0000100526],"domain_scores_gemma":[0.9993711,0.0002343127,0.0002171784,0.00004857974,0.00008589249,0.00004290017],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0141704,0.001489609,0.1684199,0.002560363,0.002953064,0.003579417,0.0007486467,0.0002767139,0.6645315,0.001051499,0.002103307,0.1381156],"study_design_scores_gemma":[0.000907345,0.01054759,0.884725,0.0001383427,0.00112198,0.01007847,0.0002797346,0.0003343711,0.07056539,0.0002932072,0.02098968,0.00001885413],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9701144,0.02023102,0.001262928,0.0007567631,0.00006808572,0.00006742277,0.0003097894,0.00003008801,0.007159541],"genre_scores_gemma":[0.9801204,0.01283025,0.001137671,0.000714246,0.0000656762,0.0000342284,0.0005801969,0.0000075452,0.004509712],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003803052,"threshold_uncertainty_score":0.01272243,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03321536608248089,"score_gpt":0.3269877369995647,"score_spread":0.2937723709170838,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}